News

The latest news from HBAN

HBAN’s MedTech Syndicate led initial €1.2M investment in Bluedrop Medical

By hban.org Thursday, 19th September 2019 | 0 comments
Filed under: Deals Done, 2019.
HBAN announces that Bluedrop Medical, a Galway based Medical device start up, has secured €3.7M in funding to help manage one of the most devastating complications of diabetes – the diabetic foot. An initial seed investment of €1.2M was led by HBAN’s MedTech Syndicate - which itself invested €340K in the seed round. Enterprise Ireland and the Western Development Commission also invested in the funding round along with other members of the investment community.  A €2.5M grant was awarded through the European Innovation Council.

CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials

By hban.org Thursday, 12th September 2019 | 0 comments
Filed under: Deals Done, 2019.
HBAN investors have contributed towards €4 million in additional financing that has been secured by CroíValve, a high potential start-up (HPSU) supported by Enterprise Ireland developing a treatment for tricuspid regurgitation (TR). This is an issue affecting over half-a-million people every year in the US and EU alone, for which there is currently no suitable solution. The financing includes €2.5 million from the European Union under their Horizon 2020 SME Instrument grant and €1.5 million from Broadview Ventures and current investors (HBAN MedTech and Irrus Syndicates, Atlantic Bridge University Fund and SOSV Ventures). The funding will accelerate the development of the company’s novel technology into First in Human studies.

Deciphex Finalise 2.3m Equity Fundraising to Accelerate Commercialisation and Research Programs

By hban.org Thursday, 25th April 2019 | 0 comments
Filed under: Deals Done, 2019.
Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.

Signum Surgical Receives €3.6 Million in Grant Funding to Support Launch of Therapy for Patients with a Common Colorectal Disease

By hban.org Monday, 8th April 2019 | 0 comments
Filed under: Deals Done, HBAN in the Media, 2019.
Signum Surgical, a company dedicated to developing minimally invasive technologies to treat colorectal diseases, today announced the company has secured €3.6 million ($4 million) through two grant funding awards. The grants include €2.3 million from the European Union Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF). Funds from these grants will support regulatory and clinical programs leading to the commercialization of the company’s BioHealxTM device, which is designed to treat anal fistula, a painful colorectal condition that affects one in 5,000 people worldwide.

CroíValve raises €3.2M in oversubscribed funding round

By hban.org Thursday, 28th March 2019 | 0 comments
Filed under: Deals Done, 2019.
CroíValve, a medtech start-up providing a safe and effective treatment for tricuspid regurgitation, today announces that it has secured €3.2 million in an oversubscribed seed financing round. The round was led by the HBAN (Halo Business Angel Network) MedTech and Irrus Syndicates, alongside Atlantic Bridge University Fund, Enterprise Ireland, SOSV and a group of cardiologists who see the treatment’s transformative potential. The funding will support the continued development of CroíValve’s innovative technology.

Talking to an Angel

By hban.org Monday, 12th November 2018 | 0 comments
Filed under: Deals Done, HBAN in the Media, 2018.
Angel investment is growing in popularity as a source of early-stage funding for start-ups. Better Business looks at the relationship between company and investor and uncovers how best to strike a deal.

HBAN’s MedTech Syndicate leads €1.1M investment in Ostoform

By hban.org Monday, 1st October 2018 | 0 comments
Filed under: Deals Done, HBAN in the Media, 2018.
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTrade Ireland, today announces that its MedTech Syndicate has led a €1.1 million Series A funding round in medical device start-up, Ostoform. HBAN Angels contributed €280,000, with venture capital investor, SOSV, Enterprise Ireland, and other angel investors making up the rest of the funding round.

The Bank of Ireland Kernel Capital Fund Invest €1.7M in Dublin Based Sytorus

By hban.org Thursday, 6th September 2018 | 0 comments
Filed under: Deals Done, Entrepreneur, 2018.
The Bank of Ireland Kernel Capital Early & Growth Stage Funds have invested €1.7M in Sytorus Ltd, this is in addition to simultaneous investment from Enterprise Ireland and private investors.  Established by Dr. John Ghent (CEO), Mike Morrissey (COO) and Hugh Jones (CPO) in 2013, Sytorus’s flagship software ‘PrivacyEngine’ is a dynamic GDPR and Data Protection SAAS product. It provides end-to-end data protection solutions to corporate clients.  The Company, with over 50 staff, is scaling rapidly and today has over 300 hundred fee paying corporate clients worldwide. Sytorus has opened offices in Stockholm and London, and this latest investment will facilitate a new office to open in Frankfurt.

HBAN angels get a 10 times return on Phorest investment

By hban.org Thursday, 2nd August 2018 | 0 comments
Filed under: Deals Done, 2018.
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces that a number of the original HBAN investors in software developer Phorest have been bought out for a sum averaging 10 times their initial investment.

Trinity spin-off ProVerum Medical raises a €3.5 million investment round including investment from HBAN Syndicates

By hban.org Tuesday, 8th May 2018 | 0 comments
Filed under: Deals Done, 2018.
ProVerum Medical, a spin-off from Trinity College Dublin with a mission to improve the lives of millions of men, has closed a $4.2 million seed investment. Atlantic Bridge University Fund led the investment round with participation from Enterprise Ireland along with several Irish and American angel investors including HBAN Medtech Syndicate, Irrus Investments, Boole and Xenium Capital. The investment will allow ProVerum to commence its first human trials in 2018 and brings the company’s total funding since it was established in 2015 to €4.6 million.

Page 1 of 3